There are no IPOs scheduled for the week ahead.
The most likely April IPOs
Despite the encouraging market rally this past week, the Renaissance IPO Volatility Index is still about double the five-year average and few companies have filed, indicating the IPO market's slow April will continue.
April's headline IPO could come from grocery giant Albertsons Companies (ACI), which is benefiting from a surge in demand and low interest rates. With successful public debuts from Keros Therapeutics (KROS) and Zentalis Pharmaceuticals (ZNTL), the most likely IPO launches include several biotechs, such as oncology-focused Ayala Pharmaceuticals